Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics crawled date : 2021 - 11 - 30 save search
Regulus Therapeutics Announces Closing of $34.6 Million Private Placement of Equity
Published: 2021-11-30 (Crawled : 23:00) - prnewswire.com
RGLS | $2.13 -4.05% -4.23% 220K
|
Health Technology
|
| O: -1.94%
H: 1.32%
C: -4.71%
therapeutics
Kymera Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for IRAKIMiD Degrader, KT-413
Published: 2021-11-30 (Crawled : 15:00) - biospace.com/
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
new drug fda clearance application drug therapeutics fda clearance
European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application for Tabelecleucel for the Treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease
Published: 2021-11-30 (Crawled : 15:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: -1.52%
H: 0.0%
C: 0.0%
treatment ema europe application therapeutics disease positive iot
AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001
Published: 2021-11-30 (Crawled : 14:30) - biospace.com/
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
AGE A | $11.1 0.0% 3.8K
|
Health Technology
|
| O: 1.43%
H: 1.39%
C: -1.42%
multiple sclerosis license technology therapeutics biotech sclerosis iot
Clarus Therapeutics Announces Issuance of Two New Patents for JATENZO® (testosterone undecanoate)
Published: 2021-11-30 (Crawled : 14:30) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -3.6%
H: 0.0%
C: -0.77%
CRXT | $0.0475
|
|
| O: 27.45%
H: 0.0%
C: 0.0%
patent therapeutics test
Intensity Therapeutics Announces New Clinical Data Presentation for its Lead Asset, INT230-6, in Breast Cancer, at the 2021 San Antonio Breast Cancer Symposium® in December
Published: 2021-11-30 (Crawled : 14:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -3.29%
H: 0.0%
C: 0.0%
therapeutics presentation cancer breast cancer symposium
Nektar Therapeutics Announces Data Presentations for its Immuno-Oncology Programs at the European Society for Medical Oncology Immuno-Oncology (ESMO-IO) Congress 2021 and the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-11-30 (Crawled : 14:00) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: -2.3%
H: 0.0%
C: 0.0%
ema europe therapeutics presentation
Blade Therapeutics Announces Positive Topline Data from Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis
Published: 2021-11-30 (Crawled : 14:00) - biospace.com/
BIOT | $10.15 -0.78% -0.2% 44K
|
|
| O: -0.1%
H: 0.3%
C: 0.3%
fibrosis xin therapeutics phase 1 positive topline cudetaxestat
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-11-30 (Crawled : 13:30) - globenewswire.com
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: -2.07%
H: 0.0%
C: 0.0%
therapeutics granted grant
TG Therapeutics Provides Regulatory Update Company to host conference call today, Tuesday, November 30, 2021 at 8:30 AM ET
Published: 2021-11-30 (Crawled : 13:30) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -44.49%
H: 0.0%
C: 0.0%
conference therapeutics oda
Better Therapeutics Appoints Deepti Sodhi Jaggi, PharmD, as Chief Strategy Officer
Published: 2021-11-30 (Crawled : 13:30) - biospace.com/
BTTX | $0.009 -65.02% 180K
|
|
| O: -0.74%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
therapeutics
Chinook Therapeutics Announces Formation of SanReno Therapeutics, a Joint Venture to Develop Kidney Disease Therapies in China
Published: 2021-11-30 (Crawled : 13:30) - globenewswire.com
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
|
| O: -1.72%
H: 0.0%
C: 0.0%
therapeutics disease china kidney therapy
Cognition Therapeutics to Host Virtual R&D Symposium December 7 on Dementia with Lewy Bodies and the Potential for Sigma-2 Modulation
Published: 2021-11-30 (Crawled : 13:30) - biospace.com/
CGTX | $1.86 1.09% 1.08% 120K
|
|
| O: 0.48%
H: 8.3%
C: 4.45%
dementia therapeutics potential symposium
NiKang Therapeutics and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Novel Combination Therapies for the Treatment of Advanced Clear Cell Renal Cell Carcinoma
Published: 2021-11-30 (Crawled : 13:30) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -4.99%
H: 0.0%
C: 0.0%
treatment renal trial therapeutics collaboration cell carcinoma
Hoth Therapeutics' Enrollment and Dosing in Second Cohort in Phase 1b Human Trial for Atopic Dermatitis Under Way
Published: 2021-11-30 (Crawled : 13:00) - ir.hoththerapeutics.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 0.06%
H: 4.32%
C: -1.8%
atopic dermatitis phase 1 dermatitis phase 1b trial therapeutics enroll phase 2b
Seres Therapeutics Announces First Patient Enrolled in Phase 1b Study of SER-155, an Investigational Microbiome Therapeutic to Reduce the Risk of Antibiotic-Resistant Bacterial Infections and Graft-Versus-Host Disease (GvHD)
Published: 2021-11-30 (Crawled : 13:00) - biospace.com/
MCRB | $0.5671 -2.93% -3.02% 3.7M
|
Health Technology
|
| O: -10.85%
H: 0.0%
C: 0.0%
disease risk bacterial infections phase 1 phase 1b bacteria iot therapeutics enroll infections phase 2b
Forma Therapeutics Announces Appointment of Acclaimed Global Sickle Cell Disease Leader Ifeyinwa Osunkwo, MD, MPH, as Senior Vice President, Chief Patient Officer
Published: 2021-11-30 (Crawled : 12:30) - biospace.com/
FMTX | $20.01 -0.15%
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
disease therapeutics
Silence Therapeutics Begins Exclusive Nasdaq Trading
Published: 2021-11-30 (Crawled : 12:30) - globenewswire.com
SLNCF | $8.0 -65.0% 630
|
Health Technology
|
| O: -2.8%
H: 2.88%
C: 2.88%
SLN | $22.75 3.32% 3.21% 310K
|
Health Technology
|
| O: 0.22%
H: 4.12%
C: 1.95%
therapeutics nasdaq
Confo Therapeutics Enters Collaborative Agreement with Regeneron
Published: 2021-11-30 (Crawled : 11:00) - biospace.com/
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: 0.0%
therapeutics collaboration
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.